Literature DB >> 783053

Circulating immune complexes in sera of patients with Burkett's lymphoma and nasopharyngeal carcinoma.

R Heimer, G Klein.   

Abstract

Sera of individuals with Burkitt's lymphoma and nasopharyngeal carcinoma, tested by consumption of hemolytic complement, were found by comparison with healthy individuals to have significantly increased levels of circulating immune complexes. The identity of the immune complexes was established by sucrose density gradient ultracentrifugation, which showed them to sediment between 10 and 19S. As they were adsorbable by rheumatoid factor--Sepharose 4B conjugates, it appeared that these complexes were composed of IgG. The complexes were retained by Concanavalin A--Sepharose columns and eluted by alpha methyl-D-mannoside, suggesting by analogy with model complexes that the antigens might be glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 783053     DOI: 10.1002/ijc.2910180307

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Circulating immune complexes in patients with breast cancer.

Authors:  K Hoffken; I D Meredith; R A Robins; R W Baldwin; C J Davies; R W Blamey
Journal:  Br Med J       Date:  1977-07-23

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

Review 3.  Suppressor mechanisms in tumor immunity.

Authors:  G T Nepom; I Hellström; K E Hellström
Journal:  Experientia       Date:  1983-03-15

4.  Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells.

Authors:  A Wells; N Koide; G Klein
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

5.  Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.

Authors:  W E Brandeis; L Helson; Y Wang; R A Good; N K Day
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

6.  [Circulating immune complexes in bronchogenic carcinoma: relation to extent of disease and to therapy (author's transl)].

Authors:  C Gropp; K Havemann; T Schärfe; H Schultz; E Schaumlöffel
Journal:  Klin Wochenschr       Date:  1979-04-17

7.  Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.

Authors:  J C Jennette
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

8.  Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.

Authors:  T A Poulton; N A Mooney; L J Nineham; F C Hay
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.

Authors:  N A Carpentier; G T Lange; D M Fiere; G J Fournie; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

10.  Severe COVID-19 Pneumonia is Associated with Increased Plasma Immunoglobulin G Agonist Autoantibodies Targeting the 5-Hydroxytryptamine 2A Receptor.

Authors:  Mark B Zimering
Journal:  Endocrinol Diabetes Metab J       Date:  2021-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.